ZIU:CA:TSX-BMO S&P/TSX 60 Index ETF (CAD)

ETF | Others |

Last Closing

CAD 57.07

Change

0.00 (0.00)%

Market Cap

CAD 0.07B

Volume

682.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.40 (-1.45%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

-0.17 (-0.50%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.26 (-1.29%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.15 (-0.40%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.17 (-0.70%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.10%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.01 (+0.04%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.68B

ETFs Containing ZIU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.45% 64% D 64% D
Dividend Return 2.37% 46% F 36% F
Total Return 19.82% 64% D 62% D
Trailing 12 Months  
Capital Gain 24.55% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.55% 55% F 55% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.28% 51% F 44% F
Dividend Return 2.28% 50% F 37% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.43% 60% D- 81% B-
Risk Adjusted Return 30.72% 49% F 48% F
Market Capitalization 0.07B 57% F 30% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.